Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Healthy women tend to lose more hair in July and April, and the least in February.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Human hair follicle stem cells show signs of low oxygen levels, which may be important for hair growth and preventing baldness.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Niacin derivatives may increase hair fullness in women with hair loss.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The HGCA tool helps identify genes that work together by analyzing their co-expression patterns.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Pulsed-intense light can significantly reduce hair, with effectiveness depending on treatment number and timing, and has mild side effects.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Minoxidil foam effectively promotes hair growth and reduces hair loss in men.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Timing of light therapy affects horse coat growth, with photoperiod being crucial.

Cepharanthine may help hair growth by increasing IGF-I in scalp cells.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.